Login / Signup

Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients.

Martin SalzmannKarolina BenesovaKristina Buder-BakhayaDimitrios PapamichailAntonia Dimitrakopoulou-StraussHanns-Martin LorenzAlexander H EnkJessica C Hassel
Published in: Cancers (2020)
Arthralgia is a common side effect in patients receiving BRAFi +/- MEKi therapy and often presents a clinical pattern similar to that observed in RA patients. Its occurrence was associated with longer-lasting tumor control.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • stem cells
  • patient reported outcomes
  • bone marrow
  • disease activity
  • skin cancer